Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
The LancetPublished 1 May 1997
Víctor Pérez, Inmaculada Gilaberte, Douglas E. Faries, Enric Álvarez, Francesc Artigas
Citations299
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The addition of pindolol to fluoxetine antidepressant treatment increases the effectiveness of fluoxettine therapy.
Abstract
The addition of pindolol to fluoxetine antidepressant treatment increases the effectiveness of fluoxetine therapy. Further work is needed to resolve whether the time to clinical improvement benefits from this combination and whether the increase in efficacy occurs with other antidepressants.
Keywords
MedicineNeuroscience
Journal of the American Statistical AssociationStatistical Methods for Survival Data Analysis.
2,863 Citations1993Peter A. Lachenbruch, Elisa T. Lee
Designing Clinical Research
1,764 Citations2006Stephen B. Hulley
BASIC INGREDIENTS Getting Started: The Anatomy and Physiology of Clinical Research Stephen B. Hulley and Steven R. Cummings Getting Ready to Estimate Sample Size: Hypotheses and Underlying Principles Warren S. Browner, Thomas B. Newman, and Stephen R.Hulley Estimating Sample Size and Power: Applications and Examples.
Archives of General PsychiatrySerotonin Function and the Mechanism of Antidepressant Action
920 Citations1990Pedro L. Delgado
The behavioral effects of rapid tryptophan depletion in patients in antidepressant-induced remission and the therapeutic effects of some antidepressant drugs may be dependent on serotonin availability are investigated.
ScienceLong-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
838 Citations1980Stephen J. Peroutka, Solomon H. Snyder
The decrease in the number of receptor sites is most marked for [3H]spiroperidol-labeled serotonin receptors and is characteristic for antidepressants of several classes.
Archives of General PsychiatryPindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors
510 Citations1994Francesc Artigas
These findings suggest that the antidepressant effects of uptake and MAO inhibitors emerge when serotonergic activity increases, and extracellular 5-HT concentration is dramatically augmented by the same doses in the vicinity of cell bodies ofserotonergic neurons, in the midbrain raphe nuclei.
International Clinical PsychopharmacologyPharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
487 Citations1994John Hyttel
Since the marketed SSRIs all show clear antidepressant effect, this receptor regulation seems not to be a prerequisite for clinical antidepressant activity.
PsychopharmacologyBinding of antidepressants to human brain receptors: focus on newer generation compounds
349 Citations1994Bernadette Cusack, Albert N. Nelson +1 more
From the in vitro data, it is expected that adinazolam, bupropion, fluoxetine, sertraline, tomoxetines, and venlafaxine not to block any of these five receptors in vivo, which can provide guidelines for the clinician in the choice of antidepressant.
Journal of Clinical PsychopharmacologyEffectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression
321 Citations1995Pierre Blier, Richard Bergeron
The results of these studies indicate that pindolol is safe when used in combination with an SSRI or moclobemide and should be tested under double-blind conditions to establish its efficacy.
Naunyn-Schmiedeberg s Archives of PharmacologyDifferential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex
222 Citations1991Albert Adell, Francesc Artigas
The antidepressant drug clomipramine (CIM) blocks 5-hydroxytryptamine (5-HT) uptake in vitro and the effect of CIM applied locally in the raphe nuclei on extracellular 5-HT in the frontal cortex was studied.
Trends in Pharmacological Sciences5-HT and antidepressants: new views from microdialysis studies
211 Citations1993Francesc Artigas
DrugsAntidepressants
192 Citations1989Matthew V. Rudorfer, William Z. Potter
A number of recent additions to this group of antidepressant medications, such as bupropion and ademetionine, incorporate novel mechanisms of action, challenging previous concepts of how antidepressants work, and offering opportunities for research into the pathophysiology of mood disorders.
European NeuropsychopharmacologyTime course of improvement under antidepressant treatment: A survival-analytical approach
189 Citations1993Hans H. Stassen, A. Delini‐Stula +1 more
The most interesting and unexpected finding of the analysis was that the time course of improvement among responders was independent of the treatment modality, and thus identical in all three groups.
NeuropsychopharmacologyEffect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain
181 Citations1996Luz Romero
Results indicate that (−)pindolol can potentiate the effects of an SSRI on extracellular 5-HT concentration by preventing the activation of somatodendritic 5- HT1A autoreceptors resulting from the blockade of the5-HT transporter in the raphe.
JAMAIncreased Antidepressant Use in Patients Prescribed β-Blockers
144 Citations1986Jerry Avorn
Prevalence rate ratios revealed a risk of being prescribed a tricyclic antidepressant of 1.5 (95% confidence interval, 1.4 to 1.7) for patients receiving β-blockers relative to patients receiving hydralazine or hypoglycemics, and β-Blocker use may be an important cause of iatrogenic depression among hypertensive patients.
PubMedFluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
137 Citations1994Gary D. Tollefson, Susan Holman +2 more
Anxiety in major depression does not appear to affect response to an antidepressant, and antidepressant selection should be determined by an agent's overall risk:benefit ratio, not the presence or absence of anxiety.
Neurochemical ResearchEnhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (−)-pindolol, an antagonist at 5-HT1A receptors
105 Citations1996Laura J. Dreshfield, David T. Wong +2 more
The present findings are consistent with the hypothesis that blockade of somatodendritic 5- HT1A autoreceptors removes the inhibitory effect exerted by the elevated 5-HT levels resulting from uptake inhibition, and can enhance5-HT release to levels beyond those achieved with uptake inhibition alone.
Journal of NeurochemistryReduction of Serotonergic Function in Rat Brain by Tryptophan Depletion: Effects in Control and Fluvoxamine‐Treated Rats
89 Citations1996N. Bel, Francesc Artigas
The administration of an amino acid mixture with the same composition and dose as those inducing a severe mood impairment in depressed patients reduces 5‐HT and 5‐HIAA concentrations in brain dialysates and significantly attenuated the release of 5‐ HT in frontal cortex and in the midbrain raphe nuclei.
International Clinical PsychopharmacologyMood disorders in the general population represent an important and worldwide public health problem
69 Citations1995Lewis L. Judd
It can be confidently concluded that depressive disorders are among the most common, disabling and costly of any of the diseases in the health care spectrum and represent significant, serious public health problems.
International Clinical PsychopharmacologyHow long to onset of antidepressant action
63 Citations1994Gary D. Tollefson, Susan Holman
The results challenge the current belief that a 3 to 4 week delay in the onset of antidepressant action is to be expected and suggest response to pharmacotherapy is likely incremental, and the rate of response highly individualized.
PsychopharmacologyUp-regulation of β1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments
43 Citations1994Esa-Pekka Pälvimäki, Aki Laakso +3 more
It is demonstrated that chronic administration of selective serotonin reuptake inhibitors, in contrast to imipramine, can cause a regional up-regulation of β1-adrenergic receptors in the rat brain.
Psychotherapy and PsychosomaticsReview of the Use of Pattern Analysis to Differentiate True Drug and Placebo Responses
35 Citations2010Rachel Rothschild, Frederic M. Quitkin
Analysis of the persistence, speed, and timing of onset of patients' improvement during antidepressant therapy reveals distinct patterns of response which are likely to be attributable to placebo and true drug effects.
Journal of Biopharmaceutical StatisticsOne-sided and two-sided tests and ρ values
33 Citations1991Gary G. Koch
Several considerations for the use of one-sided and two-sided tests are discussed: the inferential posture of the design of a study, the level of stringency for supporting a conclusion, the style for reporting p values, the perspective for interpreting results in the opposite direction to the one initially expected, and the role of confidence intervals.
PubMedCharacterizing onset in psychopharmacological clinical trials.
30 Citations1995Eugene Laska, Carole Siegel
The distributions of time to occurrence of major clinical events such as onset and response are clinically important information and a simple formula that can be used to aid in clinical decision making as to when to alter treatment if onset has not yet occurred is presented.
PubMedAre 2-week trials sufficient to indicate efficacy?
24 Citations1995Montgomery Sa
Analysis of time to response is a more sensitive measure to detect early differences in improvement and 2-week studies are proposed as a valid method to demonstrate antidepressant efficacy.
Journal of Clinical EpidemiologyThe alternative hypothesis: One-sided or two-sided?
21 Citations1989Karl E. Peace
CNS DrugsFast-Acting Antidepressants
21 Citations1994Trevor R. Norman, Brian E. Leonard
There is a need to develop drugs with less troublesome adverse effects in order to test the hypothesis that high therapeutic doses of antidepressants may lead to a rapid clinical response.
CNS DrugsThe Role of ??-Adrenoceptor Blockers in the Treatment of Psychiatric Disorders
17 Citations1996D. Bailly
Preliminary results suggest that β-adrenoceptor blockers may be useful as adjunctive medication in the treatment of depression and chronic anxiety, but further investigations are needed in these areas of patient management.
PubMedJustifying a "fast acting" claim for antidepressant drugs.
13 Citations1995Overall Je
Although alternative models provide essentially equivalent tests of significance and estimates of response latencies, a regression model--in which assessment times are recognized to be fixed independent variables and repeated quantitative measurements of clinical response are the dependent variable--is more congruent with the determinate experimental conditions and sources of error variation in antidepressant drug trials.